A role of glutamate decarboxylase in Alzheimer's disease

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 2014, Issue 4, 2014, Pages 68-72

  Burbaeva, G Sh ^a   Boksha, I S ^a   Tereshkina, E B ^a   Starodubtseva, L I ^a   Savushkina, O K ^a   Vorobyeva, E A ^a   Prokhorova, T A ^a  

^a MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

Author keywords

Alzheimer's disease; Neurochemistry

Indexed keywords

CEREBELLUM TISSUE PROTEIN; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; PEPTIDES AND PROTEINS; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE 1; GLUTAMATE DECARBOXYLASE 2; ISOENZYME;

ALZHEIMER DISEASE; ARTICLE; AUTOPSY; CEREBELLUM CORTEX; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; POLYACRYLAMIDE GEL ELECTROPHORESIS; WESTERN BLOTTING; AGED; CEREBELLUM; ENZYMOLOGY; FEMALE; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CEREBELLUM; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; MALE; MIDDLE AGED;

EID: 84905092194     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Turský T., Lassánová M. Inhibition of different molecular forms of brain glutamic acid decarboxylase with ATP. J Neurochem 1978; 30: 4: 903-905.
2. Erlander M.G., Tobin A.J. The structural and functional heterogeneity of glutamic acid decarboxylase: a review. Neurochem Res 1991; 16: 3: 215-226.
3. Tian N., Petersen C., Kash S. et al. The role of the synthetic enzyme in the control of neuronal gamma-aminobutyric acid release. Proc Natl Acad Sci USA 1999; 96: 12911-12916.
4. Wei J., Wu J.-Y. Post-translational regulation of L-glutamic acid decarboxylase in the brain. Neurochem Res 2008; 33: 1459-1465.
5. Fenalti G., Law R.H., Buckle A.M. et al. GABA production by glutamic acid decarboxylase is regulated by a dynamic catalytic loop. Nat Struct Mol Biol 2007; 14: 280-286.
6. Kaufman D.L., Houser C.R., Tobin A. Two forms of the aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distribution and cofactor interaction. J Neurochem 1991; 56: 720-723.
7. Owens D., Kriegstein A. Is there more to GABA than synaptic inhibition? Nat Rev Neurosci 2002; 3: 715-727.
8. Asada H., Kawamura Y., Maruyama K. Mice lacking the 65kDa isoform of glutamic acid decarboxylase maintain normal levels of and GABA in their brains but are susceptible to seizures. Biochem Biophys Res Commun 1996; 229: 891-895.
9. Asada H., Kawamura Y., Maruyama K. Cleft palate and decreased brain gamma-aminobutyric acid in mice lacking the 67-kDa isoform of glutamic acid decarboxylase. Proc Natl Acad Sci USA 1997; 94: 12: 6496-6499.
10. Mitew S., Kirkcaldie M.T., Dickson T.C., Vickers J.C. Altered synapses and gliotransmission in Alzheimer's disease and AD model mice. Neurobiol Aging 2013; 34: 10: 2341-2351.
11. Krantic S., Isorce N., Mechawar N. et al. Hippocampal GABAergic neurons are susceptible to amyloid-β toxicity in vitro and are decreased in number in the Alzheimer's disease TgCRND8 mouse model. J Alzheimers Dis 2012; 29: 2: 293-308.
12. Bowen D.M., White P., Flack R.H. et al. Brain-decarboxylase activities as indices of pathological change in senile dementia. Lancet 1974; 1: 7869: 1247-1249.
13. Yates C.M., Butterworth J., Tennant M.C., Gordon A. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J Neurochem 1990; 55: 5: 1624-1630.
14. Monfort J.C., Javoy-Agid F., Hauw J.J. et al. Brain glutamate decarboxylase in Parkinson's disease with particular reference to a premortem severity index. Brain 1985; 108: 2: 301-313.
15. Simpson M.D., Cross A.J., Slater P., Deakin J.F. Loss of cortical GABA uptake sites in Alzheimer's disease. J Neural Transm 1988; 71: 3: 219-226.
16. O'Halloran C.J., Kinsella G.J., Storey E. The cerebellum and neuropsychological functioning: a critical review. J Clin Exp Neuropsychol 2012; 34: 1: 35-56.
17. Villanueva R. The cerebellum and neuropsychiatric disorders. Psychiatry Res 2012; 198: 3: 527-532.
18. Buddhala C., Suarez M., Modi J. et al. Calpain cleavage of brain glutamic acid decarboxylase 65 is pathological and impairs GABA neurotransmission. PLoS One 2012; 7: 3: 33002.
19. Dirkx R. Jr., Thomas A., Li L. et al. Targeting of the 67-kDa isoform of glutamic acid decarboxylase to intracellular organelles is mediated by its interaction with the NH2-terminal region of the 65-kDa isoform of glutamic acid decarboxylase. J Biol Chem 1995; 270: 2241-2246.
20. Kanaani J., Lissin D., Kash S.F., Baekkeskov S. The hydrophilic isoform of glutamate decarboxylase, is targeted to membranes and nerve terminals independent of dimerization with the hydrophobic membrane-anchored isoform. J Biol Chem 1999; 274: 52: 37200-37209.
21. Reinikainen K.J., Paljärvi L., Huuskonen M. et al. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease. J Neurol Sci 1988; 84: 1: 101-116.
22. Boissière F., Faucheux B., Duyckaerts C. et al. Striatal expression of glutamic acid decarboxylase gene in Alzheimer's disease. J Neurochem 1998; 71: 2: 767-774.
23. Perry E.K., Gibson P.H., Blessed G. et al. Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue. J Neurol Sci 1977; 34: 2: 247-265.
24. Gluck M.R., Thomas R.G., Davis K.L., Haroutunian V. Implications for altered glutamate and GABA metabolism in the dorsolateral prefrontal cortex of aged schizophrenic patients. Am J Psychiatry 2002; 159: 7: 1165-11673.
25. Schwab C., Yu S., Wong W. et al. GABAT immunostaining in human brain and apparent loss in Alzheimer's disease. J Alzheimers Dis 2013; 33: 4: 1073-1088.